Invega Sustenna Drug Interactions: 186 Major, 577 Moderate
Invega Sustenna (Paliperidone Palmitate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Invega Sustenna. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Paliperidone can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Paliperidone can be decreased when combined with Abiraterone.
Level 1 evidence
Abrocitinib
The serum concentration of Paliperidone can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Paliperidone.
Level 2 evidence
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Paliperidone.
Level 2 evidence
Acetazolamide
The risk or severity of CNS depression can be increased when Acetazolamide is combined with Paliperidone.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Paliperidone.
Level 2 evidence
Adagrasib
The serum concentration of Paliperidone can be increased when it is combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Paliperidone can be increased when combined with Adalimumab.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Paliperidone.
Level 2 evidence
Albuterol
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Paliperidone.
Level 2 evidence
Alfentanil
The risk or severity of CNS depression can be increased when Alfentanil is combined with Paliperidone.
Level 2 evidence
Enter your NPI to unlock 20 major interactions for Invega Sustenna
Invega Sustenna (Paliperidone Palmitate) has 1284 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Invega Sustenna (Paliperidone Palmitate) has 186 major, 577 moderate, and 521 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Invega Sustenna. Always confirm against the full prescribing information.